Liawatidewi Yakob's Form 4 filing
Amphastar Pharmaceuticals, Inc. (AMPH) · filed Apr 14, 2023
- Accession no.
- 0001104659-23-045715
- Filed
- Apr 14, 2023
- Trade date
- Apr 13, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $477.7K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Liawatidewi YakobCIK 0001743927 | Director, Officer (EVP Corp Admin Center) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 13, 2023 | Common Stock | MOption exerciseAcquired | +11,494 | $20.23 | +$232,523.62 | 80,709 | Direct | |
| Apr 13, 2023 | Common Stock | SSaleDisposed | −5,000 | $41.00 | −$205,000 | 75,709 | Direct | |
| Apr 13, 2023 | Common Stock | SSaleDisposed | −6,494 | $42.00 | −$272,748 | 69,215 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 13, 2023 | Common Stock | MOption exerciseDisposed | −11,494 | $0.00 | $0 | 5,497 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.